ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 101 participants.
Also called NCT03517436
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 101 participants
- Sponsor
- Registry
-
NCT03517436
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03517436. Allocation not applicable; no masking; primary purpose treatment. Start 2018-09-18 (actual); primary completion 2020-10-02 (actual). Results posted on 2021-09-30.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- TAVR (transcatheter aortic valve replacement) with CENTERA THV
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct03517436- Content hash
6b59d5b1e5493ba5322ad8ee3183236f56537e71498f541137a5053f58dd1c29